BioBridgeXAll companies

Mulberry Biotherapeutics, Inc.

Biotechnology company · Wellesley, Massachusetts, United States

Mulberry Biotherapeutics, Inc. is a biotechnology company headquartered in Wellesley, Massachusetts, United States. Its earliest recorded incorporation is in 2020. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $698,130 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $2.1 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Mulberry Biotherapeutics at a glance

Typebiotechnology company
HeadquartersWellesley, Massachusetts, United States
Earliest incorporation on record2020
Employees (self-reported, 2020)3
SEC CIK1859602

What does Mulberry Biotherapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $698,130 in total (2020). NIH funding came from the National Institute of Neurological Disorders and Stroke.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $2.1 million sold (2021).

Frequently asked questions about Mulberry Biotherapeutics

Where is Mulberry Biotherapeutics headquartered?

Mulberry Biotherapeutics, Inc. is headquartered in Wellesley, Massachusetts, United States.

What does Mulberry Biotherapeutics do?

Mulberry Biotherapeutics, Inc. is a biotechnology company.

When was Mulberry Biotherapeutics founded?

The earliest incorporation on record for Mulberry Biotherapeutics, Inc. is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences